Stephen Bloomfield, MD
Neurological Surgery · Edison, NJNPI 1265432603
Payments from drug & device makers
Across 64 payments — averaging $33.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$798
- Medtronic$347
- Boston Scientific$217
- Novocure Inc.$209
- Servier Pharmaceuticals LLC$87
- Zimvie Inc.$83
- plus $401 from 16 others
Across 2 payments — averaging $4487.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arbor Pharmaceuticals, Inc.$9K
What the payments were for
- Food & beverage$2,142100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $798 |
| Medtronic(2 entities) | 7 | $347 |
| Boston Scientific | 4 | $217 |
| Novocure Inc. | 8 | $209 |
| Servier Pharmaceuticals LLC | 5 | $87 |
| Zimvie Inc. | 3 | $83 |
| UCB, Inc. | 5 | $81 |
| Microtransponder, Inc. | 1 | $61 |
| SK Life Science, Inc. | 2 | $31 |
| Monteris Medical Corporation | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 4 | $20 |
| EBI, LLC | 1 | $19 |
| Highridge Medical LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Biogen | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Argenx US, Inc. | 1 | $17 |
| Neurelis, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$404
- ASCENDA$165
- GENERAL DBS$108
How this compares
$2,142 in reported general payments places this provider in the 35th percentile of 174 neurological surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 80 | $6,133 |
| Baclofen | 69 | $2,301 |
| Carbamazepine | 14 | $1,087 |
| Topiramate | 41 | $971 |
| Amitriptyline Hcl | 22 | $647 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Edison
- David Wells-RothEdison$43K
- Vanessa MilanoEdison$17K
- Aria JamshidiEdison$11K
- Robert HearyNewark$1M
- Harshpal SinghHackensack$677K
- Yakov GologorskyEnglewood$612K
- Shabbar DanishNeptune$488K
- Mohammed KhanOradell$376K
- Ira GoldsteinMontclair$371K
- Simon SalernoWall Township$310K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.